EVP Chief R&D
EVP Chief R&D at ALNYLAM PHARMACEUTICALS, INC., filing insider transactions between 2026-02-13 and 2026-03-05.
| SEC ↗ |
| 2026-03-05 | ALNY | Sale | 510 | $324.59 | $166K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 106 | $319.03 | $34K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 767 | $323.84 | $248K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 272 | $324.88 | $88K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 208 | $325.67 | $68K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 102 | $320.01 | $33K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 215 | $320.81 | $69K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 289 | $321.82 | $93K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 350 | $323.01 | $113K | SEC ↗ |
| 2026-03-03 | ALNY | Sale | 640 | $320.48 | $205K | SEC ↗ |
| 2026-03-03 | ALNY | Sale | 463 | $321.50 | $149K | SEC ↗ |
| 2026-03-03 | ALNY | Sale | 317 | $319.06 | $101K | SEC ↗ |
| 2026-03-03 | ALNY | Sale | 355 | $316.74 | $112K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 353 | $327.67 | $116K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 50 | $323.62 | $16K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 97 | $324.65 | $31K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 277 | $325.63 | $90K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 421 | $326.81 | $138K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 107 | $328.71 | $35K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 182 | $329.71 | $60K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 87 | $330.85 | $29K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 101 | $331.93 | $34K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 42 | $332.64 | $14K | SEC ↗ |
| 2026-02-27 | ALNY | Sale | 127 | $328.92 | $42K | SEC ↗ |
| 2026-02-27 | ALNY | Sale | 2,259 | $330.73 | $747K | SEC ↗ |
| 2026-02-27 | ALNY | Sale | 1,159 | $331.49 | $384K | SEC ↗ |
| 2026-02-27 | ALNY | Sale | 942 | $332.48 | $313K | SEC ↗ |
| 2026-02-27 | ALNY | Sale | 140 | $334.39 | $47K | SEC ↗ |
| 2026-02-13 | ALNY | Sale | 2,242 | $310.08 | $695K | SEC ↗ |